Perrigo also said it will review its API business, which provides differentiated active pharmaceutical ingredients and finished dosage forms for the branded and generic industries.
There are nearly too many surging sectors to count.
LJPC-501 is a proprietary formulation of a protein that helps to regulate blood pressure.
In a regulatory filing, Merck said it had determined on Feb. 17 that it will book an impairment charge in connection with the research program for MK-3682.
Other movers include Incyte, Achillion and Inovio.
Look for beaten-down stocks that are trading at discounts to the value of their assets. Finding absolute bottoms in stocks is not as important as you may think.
Also up early Thursday: Bellicum and Novocure.